Ann: Update on Oculopharyngeal Muscular Dystrophy Program, page-61

I see Benitec’s PR as a reference to improving delivery but only because of new circumstances that arose recently in their pre-clinical preparations. To improve the delivery 5hey requested more time.

If - and this is a big if - and OPMD was progressing nicely but our scientific team and theirs had a serious disagreement (it happens) then at current levels Benitec is a compelling opportunity right? Add to this the other programs that are working on and all of us (except the delusional like me) would be caught on the wrong foot.